Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aneesh Kamath"'
Autor:
Aneesh Kamath, Christopher C. Imes
AimsTo: 1) compare characteristics of those who report knowing their hemoglobin A1C (A1C) value versus those who do not; 2) determine the correlation and concordance between self-reported and lab-measured A1C; and 3) examine factors associated with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af361546bee2afa98bfcffc99116725b
https://doi.org/10.1101/2023.05.10.23289782
https://doi.org/10.1101/2023.05.10.23289782
Autor:
Stanley Cohan, Tiffany Gervasi-Follmar, Aneesh Kamath, Vineetha Kamath, Chiayi Chen, Kyle Smoot, Elizabeth Baraban, Keith Edwards
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Background Natalizumab (NTZ) is a highly effective disease modifying treatment for relapsing multiple sclerosis (RMS), but it increases risk of progressive multifocal leukoencephalopathy (PML) in patients with serum anti- John Cunningham virus (JCV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4fd6e832753a7b9cfe59fe6fefffdd9
https://pubmed.ncbi.nlm.nih.gov/34950502
https://pubmed.ncbi.nlm.nih.gov/34950502
Autor:
Aneesh Kamath, Keith R. Edwards, Vineetha Kamath, Jason P. Mendoza, Natalia Penner, Bing Zhu, Tatiana Plavina, Caroline Woodward, Judy Button
Publikováno v:
Multiple Sclerosis and Related Disorders. 51:102861
Background Biomarkers are a useful and reliable measure of disease activity in many fields of medicine. Axonal and glial biomarkers in multiple sclerosis (MS) are being applied more often as technology is improving and becoming increasingly reliable.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9830914977145a761b3012faf5768763
https://doi.org/10.1016/j.msard.2021.102861
https://doi.org/10.1016/j.msard.2021.102861